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ABSTRACT
Introduction: To assess differences in
associations of ocular perfusion pressure (OPP)
as well as retinal and retrobulbar blood flow
between men and women with primary open
angle glaucoma (OAG).
Methods: A total of 116 patients with OAG
(age 66.9 ± 10.9 years, 70 females) participating
in the Indianapolis Glaucoma Progression Study
were assessed for OPP, retinal microcirculation,
and retrobulbar blood flow. Confocal scanning
laser Doppler flowmetry measured peripapillary
retinal capillary blood flow. Color Doppler
imaging measured peak systolic (PSV) and
diastolic blood flow velocities and vascular
resistance in the ophthalmic (OA), central retinal
(CRA), and nasal and temporal short posterior
ciliary arteries (N/T PCA). Bivariate Spearman
correlation and multivariate linear regression
analyses were performed.
Results: In female patients with OAG, inferior
retinal capillary flow was associated with OPP
(r = 0.246, P = 0.044). In men, superior and
inferior sector retinal blood flow was
associated with OPP (r = -0.402, P = 0.006
and r = -0.357, P = 0.016, respectively). There
was no statistically significant association
between OPP and retrobulbar blood vessel flow
velocities in male patients with OAG but there
was an association between OA and TPCA PSV
and OPP in female patients with OAG
(r = 0.290, P = 0.015 and r = 0.357, P = 0.002,
respectively). In female patients with OAG,
multivariate regression showed no statistically
significant effect of any variable on the superior
retinal capillary blood flow, with CRA PSV as a
sole predictor to the inferior retinal sector
(partial rho = 0.302, P = 0.015) and in male
patients with OAG, superior sector retinal
capillary blood flow was independently
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associated with intraocular pressure (partial
rho = -0.371, P = 0.016) and OPP (partial
rho = -0.456, P = 0.002) with a trend of
association with OPP in the inferior retina
(partial rho = -0.301, P = 0.053).
Conclusions: There was a positive linear
association between retinal microcirculation
and OPP in females and a negative association
in males. Male and female patients with OAG
may differ in their vascular autoregulation in
response to changes in OPP.
Keywords: Glaucoma; Hormone; Ocular blood
flow; Ocular perfusion pressure
INTRODUCTION
Primary open angle glaucoma (OAG) is a
multifactorial optic neuropathy characterized
by progressive retinal ganglion cell death and
visual field loss. Despite being a leading cause of
impaired vision worldwide, the risk factors for
OAG have not been fully defined. Some
speculate that gender plays a role in OAG risk
and pathogenesis and it is well established in
the literature that there are physiologic and
ocular differences between men and women
that may explain a difference between the two
with respect to glaucoma.
The difference in OAG predilection between
men and women is conflicting in the current
literature. A number of clinical trials show men
to be disproportionately affected in OAG
incidence, prevalence, and risk [1–6]. However,
a few studies actually show women to be
disproportionately affected, including the
Arizona Eye Study [7, 8]. Further, a multitude
of studies have found no difference in the rate
of glaucoma between men and women,
including the Baltimore Eye Survey, Beaver
Dam Eye Study, and Blue Mountains Eye
Study [9–13].
Not only has the incidence of OAG been
noted to differ between the sexes in current
literature, significant ocular structural
disparities have also been noted. Women’s
eyes are on average more than 1 mm shorter
than men’s are. Average applanation
tonometric readings are more than half a unit
higher in women, and women’s lens and
corneal curvatures have been found to be
steeper than those in men are [14]. However,
no relationship has yet to be established
between these differences and glaucoma
incidence or pathogenesis between the genders.
Another possible explanation for the
potential differences in glaucoma predilection
and pathogenesis between men and women is
hormonal status. The relationship between
estrogen status and glaucoma is well
established in the literature. The Rotterdam
Study found that women that were
postmenopausal before the age of 45 were at
higher risk of developing glaucoma than those
who went through menopause after 45 years of
age suggesting that estrogen might actually be
protective against the development of
glaucoma [15]. The Rotterdam study also
found that men with a specific haplotype of
an estrogen receptor beta (ESR2) had an
increased incidence of glaucoma. While the
function of this receptor is still unknown, this
points towards hormonal status playing a role
in glaucoma incidence [16]. Another study
found that pregnancy, where estrogen levels
are relatively elevated, actually impairs
glaucoma progression [17]. Siesky et al. [18]
determined that premenopausal women had
lower intraocular pressure (IOP), the only
known treatable risk factor for glaucoma, than
postmenopausal women. Further, the Blue
Mountains Eye Study found that women
with later onset of menses and increased
parity had an increased risk of OAG,
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possibly explained by decreased exposure to
endogenous estrogens [19].
While evidence points to estrogen levels
playing a role in the incidence of glaucoma,
estrogen is also believed to affect ocular blood
flow. Choroidal pulsatile ocular blood flow was
found to be higher in premenopausal than
postmenopausal women [20]. Studies looking
at hormone replacement therapy (HRT) and
ocular blood flow have determined that
retrobulbar blood flow actually increases after
instatement of HRT [21, 22]. There is conflicting
evidence on the difference in retrobulbar blood
flow between pre- and postmenopausal women.
Altintas et al. [22] found higher retrobulbar flow
in premenopausal compared to postmenopausal
women. Siesky et al. [18], however, found no
significant difference in retinal capillary and
retrobulbar blood flow between pre- and
postmenopausal women.
Over the past several decades, dozens of
studies have linked abnormalities in ocular
perfusion pressure (OPP) and blood flow to
glaucomatous optic neuropathy. Specifically,
blood flow deficiencies of the retinal,
choroidal, and retrobulbar circulations have
been reported in patients with OAG [23]. In
large population-based trials, reduced OPP has
been linked to both the prevalence and
incidence of glaucoma [24–27].
Given the potential difference in prevalence
of glaucoma between the sexes, the relationship
between hormonal status and glaucoma, and
the relationship between hormonal status and
ocular blood flow, it is important to compare
ocular blood flow in men and women. While
studies have looked at effects of menopausal
status and HRT on ocular blood flow, the
literature is lacking in studies that directly
compare ocular blood flow between the sexes.
This is important to investigate considering the
growing evidence linking changes in ocular
blood flow and glaucoma [23–27].
The purpose of this study is to directly
compare ocular blood flow in men and
women by looking at OPP, retrobulbar blood
flow, and retinal blood flow considering the
larger picture of whether men and women differ
in their glaucoma pathogenesis secondary to
differences in ocular blood flow.
METHODS
A pilot analysis using data from the
Indianapolis Glaucoma Progression Study was
performed. This investigation was conducted at
the Glaucoma Research and Diagnostic Center
in conjunction with the Department of
Ophthalmology and Division of Biostatistics at
the Indiana University School of Medicine. All
experimental procedures conformed to the
tenets of the Declaration of Helsinki and were
approved by the institutional review board at
the Indiana University School of Medicine and
patients signed informed consent before
enrollment. A total of 116 patients with OAG
participating in the Indianapolis Glaucoma
Progression Study were assessed for OPP,
retinal microcirculation, and retrobulbar blood
flow. Various baseline measurements were also
taken to ensure continuity between the two
groups with respect to systemic and ocular
structural and functional parameters as
outlined below.
Men and women were first assessed for
baseline IOP and systemic blood pressure.
Brachial artery blood pressure was assessed
after a 5-min rest period using a calibrated
automated sphygmomanometer. IOP was
assessed using Goldmann applanation
tonometry (Haag-Streit. Mason, OH, USA).
OPP was calculated using systolic blood
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pressure and IOP with the following equation,
OPP = 2/3 mean arterial pressure - IOP. Visual
field was assessed using 24-2 standard
automated perimetry (SITA) (Carl Zeiss
Meditec, Inc. Dublin, CA, USA). Heidelberg
Retinal Tomograph (Heidelberg Engineering,
Carlsbad, CA 92008, USA), which uses a
special laser to take three-dimensional
photographs of the optic nerve and
surrounding retina, was used to look at cup to
disc ratio and retinal nerve fiber layer thickness.
The instrument uses multiple two-dimensional
images to construct a three-dimensional image
of the entire optic nerve.
Color Doppler imaging (CDI) of the
retrobulbar blood vessels was conducted using
Philips HDI 5000 SonoCT Ultrasound System
with the microvascular small parts clinical
option (Philips Medical Systems, Bothell, WA,
USA) with a 7.5 MHz linear probe as described in
detail previously [13–16]. CDI measurements
were taken in the ophthalmic (OA), central
retinal (CRA), and nasal and temporal (NPCA/
TPCA) short posterior ciliary arteries. In each
vessel, peak systolic (PSV) and end diastolic
(EDV) velocities were determined and
Pourcelot’s vascular resistive index (RI) was
calculated (RI = (PSV - EDV)/PSV). These
techniques have been previously shown to
yield reproducible measurements of retrobulbar
blood flow velocities and peripheral vascular
resistance [28–31].
Confocal scanning laser Doppler flowmetry
(Heidelberg Retinal Flowmeter, Heidelberg
Engineering, Heidelberg, Germany) was used
to measure perfusion within peripapillary
retinal capillary beds of the superior and
inferior temporal fields. Flow was measured as
number of zero flow pixels and number of pixels
falling into the 10th, 25th, 50th, 75th, and 90th
percentiles of total flow thereby describing the
total vascularity of the fundus. The technique
has been described in detail previously [32].
Statistical Analysis
Bivariate Spearman correlation and multivariate
linear regression analysis were performed.
RESULTS
A total of 116 patients (age 66.9 ± 10.9 years,
70 women) with OAG participating in the
Indianapolis Glaucoma Progression Study were
assessed in female patients with OAG, the
inferior retinal capillary flow was positively
associated with OPP (r = 0.246, P = 0.044). In
male patients with OAG, both superior and
inferior sector retinal blood flow were
negatively associated with OPP (r = –0.402,
P = 0.006 and r = -0.357, P = 0.016,
respectively) (Figs. 1, 2). There was no
statistically significant association between
OPP with the retrobulbar blood vessel flow
velocities in male patients with OAG but there
was an association between OA and TPCA PSV
and OPP in female patients with OAG
(r = 0.290, P = 0.015 and r = 0.357, P = 0.002,
respectively); an effect that was independent of
age in the multivariate analysis. In female
patients with OAG, multivariate regression
showed no statistically significant effect of any
variable on the superior retinal capillary blood
flow, with CRA PSV as a sole predictor to the
inferior retinal sector (partial rho = 0.302,
P = 0.015) and in male patients with OAG,
superior sector retinal capillary blood flow was
independently associated with IOP (partial
rho = -0.371, P = 0.016) and OPP (partial rho =
-0.456, P = 0.002) with a trend of association
with OPP in the inferior retina (partial rho =
-0.301, P = 0.053).
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Table 1 contains data comparing
measurements of IOP, systemic blood pressure,
OPP as well as measurements of visual field as
measured by 24–2 standard automated
perimetry, including mean deviation and
pattern standard deviation, and measurements
of structure as measured by Heidelberg Retinal
Tomograph, including cup to disc ratio and
mean retinal nerve fiber layer thickness, in men
and women in our pilot study. This table shows
that men and women in our study did not
greatly differ with regard to these
measurements.
DISCUSSION
In recent years, observational differences have
been made between men and women with
OAG. Conflicting evidence has been found as
it relates to gender and OAG predilection with
the majority pointing towards either men
having increased predilection for glaucoma, or
there being no difference between men and
women. The Barbados Eye Study found the
9-year incidence of OAG was 4.9% in men and
4.1% in women [1]. Using published estimates
from 25 studies and including 1,355 patients
with OAG, Rudnicka et al. [6] found that the
prevalence of OAG in men was 1.37 times
greater than in women. Dielemans et al. [2]
found that men had more than a 3 times greater
risk of having OAG than women, with an odds
ratio of 3.6. A number of other studies found a
higher prevalence in men compared with
women [3–5].
A multitude of studies, most notably
including the Baltimore Eye Survey, Beaver
Dam Eye Study, and Blue Mountains Eye
Study have shown there to be no difference in
OAG prevalence and incidence between men
and women [9–13]. Few studies have found
women to have an increased prevalence of OAG
compared with men [7, 8]. Many theories exist
as to why this difference in predilection may
exist and that men and women have differences
with respect to glaucoma.
Men and women have known structural
differences [14] that could contribute to
differences in OAG pathogenesis between the
sexes. However, the more well established
theory in the literature centers around
Fig. 1 The relationship between inferior retinal mean
blood ﬂow and ocular perfusion pressure in female patients
with glaucoma
Fig. 2 The relationship between inferior retinal mean
blood ﬂow and ocular perfusion pressure in male patients
with glaucoma
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hormonal status. The Rotterdam study has
delved deeply into this issue and these
researchers believe that estrogen may have a
protective effect based upon their findings that
women who went into menopause later had a
decreased incidence of glaucoma and that men
with the ESR2 haplotype had a 3.6-fold
increased risk of OAG [15, 16]. Taken in
conjunction with results of the present study,
it is possible that ocular blood flow may play
into this theory and ocular blood flow and
hormonal status may be related as well as
related differences in men and women with
regards to OAG. Additionally, lower IOP, the
only known treatable risk factor for glaucoma,
was found in premenopausal women compared
with postmenopausal women [18]. This too is
interesting in conjunction with results of this
study as the authors found no significant
difference between men and women with
regards to IOP, but we did in ocular blood
flow. This supports the idea that ocular blood
flow may be a separate risk factor for OAG
differing between the sexes.
To further support the potential relationship
between ocular blood flow, hormonal status,
and glaucoma incidence, studies have shown
that estrogen specifically affects ocular blood
flow. Premenopausal women had a significantly
higher rate of pulsatile ocular blood flow than
post-menopausal women [20]. In looking at
retrobulbar blood flow, it was found that
pulsatility indices in the CRA declined after
HRT was initiated [21]. Altintas et al. [22] also
looked at HRT and retrobulbar blood flow and
found that the RI in the CRA, TPCA, and NPCA
had decreased after 2 months of HRT. In this
same study, resistivity indices in the CRA,
TPCA, and NPCA were higher in
postmenopausal women than premenopausal
women, also pointing to estrogen having a
positive effect on ocular blood flow. The
mechanism of this relationship is not well
defined, however, and may be related to
differences found in the present study between
men and women with respect to ocular blood
flow.
Furthermore, female menopausal status is
known to have systemic vascular effects in
women [18]. Estrogen has been shown to have
a protective effect on coronary artery disease
and vascular changes have been noted as early
as 1-week postsurgical menopause in a group of
women [33]. This supports the theory that











Intraocular pressure 16.6 4.8 16.7 4.4
Systolic blood pressure 135.5 23.3 136.1 14.9
Diastolic blood pressure 85.1 12.8 83.1 10.3
Ocular perfusion pressure 51.3 12.1 50.5 7.6
Mean deviation -3.8 3.7 -2.7 3.2
Pattern standard deviation 4.7 3.8 3.8 2.9
Cup to disc area 0.39 0.17 0.41 0.18
Mean retinal nerve ﬁber layer thickness 0.19 0.08 0.19 0.07
Page 6 of 10 Ophthalmol Ther (2012) 1:1
123
ocular blood flow is related to the protective
effects of estrogen against the development of
glaucoma and that ocular blood flow could be
related to the potential difference between men
and women in glaucoma predilection and
pathogenesis. However, to the authors’
knowledge, no studies had directly compared
retinal and retrobulbar blood flow in men and
women. Before the present study, such a
relationship has only been speculated based
on hormonal status’ effect on ocular blood flow.
This study supports the idea that men and
women do differ with respect to ocular blood
flow. Women had a positive relationship
between retinal blood flow and OPP while
men had a negative relationship between the
two. Additionally, men had no relationship
between retrobulbar blood flow and OPP, but
in women there was a significant relationship
between OA and TPCA PSV and OPP. When
taken in conjunction with evidence of the
relationship between ocular blood flow and
glaucoma incidence and pathogenesis [23–27],
the results of this study suggest a possible
difference in vascular autoregulation between
male and female patients with glaucoma during
fluctuations of OPP. Autoregulation is defined
as the intrinsic ability to maintain perfusion
despite changes in the vasculature by
vasodilation or constriction. It is theorized
that autoregulation may be disrupted in
patients with OAG, leading to ischemic
damage to the optic nerve and retinal
ganglion cells, and thus may play a role in
OAG pathogenesis [34]. This study, however,
was limited by the fact that the authors were
not able to measure fluctuations in OPP thus
this theory on differences in men and women
with respect to autoregulation is merely
speculative.
This study has several limitations in addition
to the inability to measure fluctuations in OPP
as noted above. The data were from a pilot
analysis of data from the Indianapolis
Glaucoma Progression Study and thus the
authors looked at an uneven number of men
and women, with women representing about
60% of the study patients. Additionally,
hormonal status of the female patients was
unknown and thus while speculation can be
made upon the relationship between estrogen,
ocular blood flow, and glaucoma, this study
only provides information on ocular blood flow
differing between the sexes. Finally, each
imaging technology has inherit limitations;
within this investigation CDI evaluated blood
flow velocities and calculated vascular
resistance but did not analyze direct flow
assessments due to lack of blood vessel
diameter [28–31].
This study suggests the possibility of a
difference in pathogenesis between men and
women in glaucoma secondary to differences in
ocular blood flow, especially given the
similarities between this study populations
with regard to other measurements of
glaucoma as evidenced in Table 1. Based on
the current literature and theories, perhaps this
difference is related to women’s increased
exposure to estrogen and estrogen having a
positive effect on autoregulation of ocular blood
flow. Whether or not this difference in ocular
blood flow is related to hormonal status and,
ultimately, the incidence of glaucoma between
men and women is yet to be determined.
Further studies need to be conducted
comparing men and women with respect to
glaucoma incidence and progression and the
relationship to hormonal status and ocular
blood flow. This disparity in the relationship
between retinal and retrobulbar blood flow and
OPP in men compared with women supports
the idea that men and women have ocular
differences that may be contributory to
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differences in glaucoma between the two,
especially considering the profound
relationship in the literature between ocular
blood flow and glaucoma incidence and
progression [23–27]. Further studies also need
to be done on how differences in ocular blood
flow may contribute to glaucoma pathology as
this may signal a different level of blood flow
importance to the disease process in women
compared with men with glaucoma.
CONCLUSION
This ultimately raises the larger question, of
whether sex should be considered when
patients with glaucoma are evaluated.
Currently no approved management of
glaucoma involves treatment of ocular blood
flow, but growing evidence does point to a
vascular consideration, especially given the
larger number of patients who experience
glaucoma progression despite significantly
lowered IOP [35, 36]. More studies need to be
done not only on the differences in
pathogenesis of glaucoma between the sexes,
but also on differences between the sexes
regarding risk factors, including ocular
circulation.
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